Regenerative Medical Technology Group Inc.
RMTG
$0.09
$0.00-4.44%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -62.07% | -15.30% | -118.24% | -390.78% | 30.48% |
| Total Depreciation and Amortization | 65.69% | 88.61% | 453.60% | -14.30% | -33.98% |
| Total Amortization of Deferred Charges | 496.03% | -- | 17,854.55% | 684.27% | -94.39% |
| Total Other Non-Cash Items | 589.82% | -98,690.91% | -99,700.00% | 34,650.00% | 19,685.71% |
| Change in Net Operating Assets | 115.41% | 61.65% | 38.30% | 212.60% | -43.50% |
| Cash from Operations | 155.51% | 78.81% | -89.93% | -174.64% | -761.62% |
| Capital Expenditure | 60.67% | -- | -434.40% | -319.40% | -109.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 60.67% | -- | -434.40% | -319.40% | -109.87% |
| Total Debt Issued | -102.42% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.42% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.07% | 83.36% | -169.52% | -295.44% | 937.93% |